Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
基本信息
- 批准号:10625369
- 负责人:
- 金额:$ 42.64万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-06-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:AcuteAcute Renal Failure with Renal Papillary NecrosisAdverse eventAtrophicAttenuatedBilateralBlood VesselsBlood flowCardiacCell NucleusCellsCessation of lifeChromatinChronicChronic Kidney FailureCicatrixCoupledDataDevelopmentDisease ProgressionElectrolytesEndothelial CellsEndotheliumEnzymesEpigenetic ProcessEpithelial CellsEpitheliumFibroblastsFibrosisFosteringGenesHDAC1 geneHistone DeacetylaseHistone Deacetylase InhibitorImmuneIn VitroInjuryInjury to KidneyKidneyKidney DiseasesKnock-outKnockout MiceKnowledgeLiquid substanceMediatingMicroRNAsModelingModificationMolecularMyofibroblastOperative Surgical ProceduresOutcomePathologicPathway interactionsPatientsPatternPericytesProtein IsoformsProteinsPublishingRenal functionReperfusion InjuryRiskSignal PathwaySignal TransductionSourceStructure of glomerular mesangiumTGFB1 geneTestingTherapeuticTubular formationUp-RegulationUreteral obstructionattenuationbeta catenincell typedifferential expressionepigenetic regulationepithelial repairexperimental studyglomerulosclerosishealinghypoperfusionin vivointerstitialinterstitial cellkidney cellkidney cortexkidney fibrosisknock-downmouse modelnovelnovel therapeutic interventionpreventrepairedresponsetranscriptome sequencingtranscriptomics
项目摘要
SUMMARY
Episodes of acute kidney injury (AKI) are associated with an increased risk for chronic kidney
disease (CKD); a permanent loss of kidney function. Following AKI, crosstalk between epithelial
and interstitial cells is critical for kidney healing (adaptive response) but if prolonged fosters CKD
(maladaptive). Evidence suggests that epigenetic modifiers, such as histone deacetylases
(HDACs) and microRNAs (miRs), can become deranged leading to pathological conditions. For
example, activation of kidney HDACs following AKI is hypothesized to exacerbate injury; however,
we and others have demonstrated that HDACs are also necessary for epithelial repair. A gap in
our knowledge exists in the kidney cell type specific, HDAC isoform-dependent mechanisms of
repair or chronic injury in response to AKI. We identified that following AKI, HDAC1 is significantly
increased in the kidney cortex including in fibroblasts and pericytes. Utilizing inducible, fibroblast-
specific HDAC1 knockout (KO) mice, we found that fibroblast/pericyte HDAC1 results in
myofibroblast activation and fibrosis. One potential target of HDAC1 may be miR-215-5p
(miR215). miR215 is reduced by in vivo HDAC inhibition, and is increased by HDAC1 in kidney
fibroblast/pericyte cells. We provide data that fibroblast miR215 is profibrotic. From these data,
we propose to test the following hypotheses: Aim 1: To test the hypothesis that AKI-mediated
fibrosis is dependent on activation of fibroblast/pericyte cell HDAC1. Aim 2: To test the
hypothesis that AKI promotes miR215 dependent interstitial fibrosis in the kidney. The
experiments proposed in this R01 will provide deep molecular evidence of epigenetic regulation
of the kidney fibroblast/pericytes following AKI and we will determine the dynamic epigenetic
patterning during CKD transition. Using both biased and unbiased approaches will result in the
identification of novel pathways that likely be of therapeutic value to help attenuate AKI-CKD
transition.
概括
急性肾脏损伤(AKI)发作与慢性肾脏风险增加有关
疾病(CKD);肾功能的永久丧失。跟随Aki,上皮之间的串扰
和间质细胞对于肾脏愈合至关重要(自适应反应),但如果延长了fosters ckd
(适应不良)。证据表明表观遗传修饰剂,例如组蛋白脱乙酰基酶
(HDACS)和microRNA(mirs)可能会造成病理状况的毁灭。为了
例如,假设AKI后肾脏HDAC的激活会加剧损伤。然而,
我们和其他人已经证明,HDAC对于上皮修复也是必需的。差距
我们的知识存在于特异性肾细胞类型的HDAC同工型依赖性机制中
响应AKI的修复或慢性损伤。我们确定遵循AKI,HDAC1显着
肾脏皮质的增加,包括成纤维细胞和周细胞。利用可诱导的成纤维细胞 -
特定的HDAC1敲除(KO)小鼠,我们发现成纤维细胞/周细胞HDAC1导致
肌纤维细胞激活和纤维化。 HDAC1的一个潜在目标可以是miR-215-5p
(mir215)。 MiR215通过体内HDAC抑制减少,并通过HDAC1在肾脏中增加
成纤维细胞/周细胞。我们提供的数据表明成纤维细胞miR215是纤维化的。从这些数据,
我们建议检验以下假设:目标1:测试AKI介导的假设
纤维化取决于成纤维细胞/周细胞细胞HDAC1的激活。目标2:测试
假设AKI促进了肾脏中依赖的MiR215依赖性间质纤维化。这
在本R01中提出的实验将提供表观遗传调节的深层分子证据
AKI之后的肾脏成纤维细胞/周细胞,我们将确定动态表观遗传学
CKD过渡期间的图案。使用偏见和公正的方法将导致
识别可能具有治疗价值的新途径,以帮助减轻AKI-CKD
过渡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kelly Hyndman其他文献
Kelly Hyndman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kelly Hyndman', 18)}}的其他基金
Deep South KUH Premier Research- Interdisciplinary Mentored Education (PRIME) Networking Core
深南 KUH 顶级研究 - 跨学科指导教育 (PRIME) 网络核心
- 批准号:
10724929 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10445263 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10295288 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10175553 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Epigenetic Regulation of Kidney Fibrosis following AKI
AKI 后肾脏纤维化的表观遗传调控
- 批准号:
10413226 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Lysine Acetylation and the Regulation of Vasopressin/Aquaporin System in the Principal Cell
主细胞中赖氨酸乙酰化和加压素/水通道蛋白系统的调节
- 批准号:
10662292 - 财政年份:2021
- 资助金额:
$ 42.64万 - 项目类别:
Novel mechanisms of HDAC1 regulation of renal collecting duct function
HDAC1调节肾集合管功能的新机制
- 批准号:
8868322 - 财政年份:2015
- 资助金额:
$ 42.64万 - 项目类别:
Novel mechanisms of HDAC1 regulation of renal collecting duct function
HDAC1调节肾集合管功能的新机制
- 批准号:
9766242 - 财政年份:2015
- 资助金额:
$ 42.64万 - 项目类别:
相似海外基金
Wearable alert system for detecting postoperative hypotension
用于检测术后低血压的可穿戴警报系统
- 批准号:
10760370 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Real-time Prediction of Adverse Outcomes After Surgery
实时预测手术后不良后果
- 批准号:
10724048 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Mechanisms of subclinical renal injury in females following AKI: implications for adverse pregnancy outcomes
AKI 后女性亚临床肾损伤的机制:对不良妊娠结局的影响
- 批准号:
10568101 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
A Randomized Clinical Trial of the Safety and FeasibiLity of Metformin as a Treatment for sepsis induced AKI (LiMiT AKI)
二甲双胍治疗脓毒症引起的 AKI (LiMiT AKI) 的安全性和可行性的随机临床试验
- 批准号:
10656829 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别:
Multiple Chronic COnditions: MultiPle dAta SouRcEs (MC COMPARE)
多种慢性病:多种数据源(MC COMPARE)
- 批准号:
10726452 - 财政年份:2023
- 资助金额:
$ 42.64万 - 项目类别: